Precision Proteomics is a pre-clinical stage biotechnology company commercializing a novel platform for the development of next-generation precision medicines. Precision’s technology can systematically and quantitatively profile activations of key signal pathways that drive pathogenesis and the development of resistance to therapy.
Precision Proteomics